Enhancing Medical Compliance and Health-related Quality of Life of Patients With Epilepsy
NCT ID: NCT02547389
Last Updated: 2015-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
144 participants
INTERVENTIONAL
2014-01-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In order to design an effective intervention on the management of epilepsy, the drug management of epilepsy by community health workers was evaluated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavioral and Educational Tools to Improve Epilepsy Care
NCT02646631
Enhancing Antiepileptic Drug Adherence
NCT02165306
Managing Epilepsy Well- WebEase Project
NCT00726076
Study The Knowledge and Attitude Towards Epilepsy Among Relatives of People With Epilepsy and Their Impact on The Patient's Quality of Life
NCT05671575
Evaluation Of A Mobile Messaging Service In Improving Adherence Of Anti-Seizure Medications
NCT05321641
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group (IG)
IG additionally received community health programs with health workers(intensive education, consultation services, maintenance of anepilepsy tracking card, and repeated reminders).
Community support group
Control Group (CG)
Patients in the CG were supplied with only printed epilepsy educational module
Printed material Supported
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Community support group
Printed material Supported
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must have a seizure frequency of at least two seizures in a 6 month period of time.
* Patients must be on at least one anti-epileptic medication.
* Patients must be able to report seizure frequency with either a paper or electronic diary.
* Patients must be able to read and understand either English or Hindi.
* Patients must be able to complete questionnaires and provide informed consent to this study.
Exclusion Criteria
* Severe depression, anxiety, or psychosis
* Recent problem with substance abuse.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Macmillan Research Group UK
INDUSTRY
NMP Medical Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hitesh K Nayak
Role: PRINCIPAL_INVESTIGATOR
NMP Medical Research Institute
Neha Sharma, PhD
Role: STUDY_DIRECTOR
Macmillan Research Group UK
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
nmp/22181
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.